Low calcium dialysate combined with CaCO3 in hyperphosphatemia in hemodialysis patients

Gao,Zhuo; Lun,Li-De; Li,Xin-Lun

doi:10.3892/etm.2013.1067

Low calcium dialysate combined with CaCO3 in hyperphosphatemia in hemodialysis patients

Authors:
- Zhuo Gao
- Li-De Lun
- Xin-Lun Li
View Affiliations

Affiliations: Department of Nephrology, Air Force General Hospital, Beijing 100142, P.R. China
Published online on: April 17, 2013 https://doi.org/10.3892/etm.2013.1067
Pages: 1732-1736

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

This aim of this study was to observe the effects of the application of low calcium dialysate (LCD) combined with oral administration of CaCO3 in the treatment of hyperphosphatemia, as well as blood Ca2+, calcium-phosphate product (CPP), parathyroid hormone (PTH) and blood pressure in patients undergoing hemodialysis. Thirty-one maintenance hemodialysis (MHD) patients with hyperphosphatemia, but normal blood Ca2+, underwent dialysis with an initial dialysate Ca2+ concentration (DCa) of 1.50 mmol/l for six months and then with 1.25 mmol/l for six months. The patients who underwent dialysis with a DCa of 1.25 mmol/l were treated orally with 0.3 g CaCO3 tablets three times a day. In the third and sixth months [observation end point (OEP)] of the dialysis, the concentrations of Ca2+, phosphorus and intact PTH (iPTH) were measured; blood pressure and side-effects prior to and following dialysis were also observed. The Ca2+, CPP and iPTH levels increased (P<0.05) in the sixth month of treatment with a DCa of 1.50 mmol/l. However, the Ca2+ concentration declined to a certain degree, CPPs decreased significantly (P<0.05) and the iPTH concentration increased following treatment with a DCa of 1.25 mmol/l for six months. The incidence rate of adverse effects of LCD was 12.9% (4/31); the effects were mainly muscle spasms, hypotension and elevated PTH. The periodic application of LCD combined with the oral administration of CaCO3 effectively reduced serum phosphorus and CPPs among MHD patients with hyperphosphatemia, indicating that the treatment may be used clinically.

View Figures

View References

1.	Spasovski GB: Bone health and vascular calcification relationships in chronic kidney disease. Int Urol Nephrol. 39:1209–1216. 2007. View Article : Google Scholar : PubMed/NCBI
2.	Kyriazis J, Katsipi I, Stylianou K, Jenakis N, Karida A and Daphnis E: Arterial stiffness alterations during hemodialysis: the role of dialysate calcium. Nephron Clin Pract. 106:c34–c42. 2007. View Article : Google Scholar : PubMed/NCBI
3.	Severi S, Grandi E, Pes C, Badiali F, Grandi F and Santoro A: Calcium and potassium changes during haemodialysis alter ventricular repolarization duration: in vivo and in silico analysis. Nephrol Dial Transplant. 23:1378–1386. 2008. View Article : Google Scholar
4.	Derici U and El Nahas AM: Vascular calcifications in uremia: old concepts and new insights. Semin Dial. 19:60–68. 2006. View Article : Google Scholar : PubMed/NCBI
5.	Kuhlmann MK: Phosphate elimination in modalities of hemodialysis and peritoneal dialysis. Blood Purif. 29:137–144. 2010. View Article : Google Scholar : PubMed/NCBI
6.	Chertow GM, Burke SK and Raggi P; Treat to Goal Working Group: Sevelamer attenuates the progression of cardiovascular calcification in hemodialysis patients. Kidney Int. 62:245–252. 2002. View Article : Google Scholar : PubMed/NCBI
7.	Näppi SE, Virtanen VK, Saha HH, Mustonen JT and Pasternack AI: QTc dispersion increase duing hemodialysis with low-calcium dialysate. Kidney Int. 57:2117–2122. 2000.PubMed/NCBI
8.	Miller JE, Kovesdy CP, Norris KC, et al: Association of cumulatively low or high serum calcium levels with mortality in long-term hemodialysis patients. Am J Nephrol. 32:403–413. 2010. View Article : Google Scholar : PubMed/NCBI
9.	Toussaint N, Cooney P and Kerr PG: Review of dialysate calcium concentration in hemodialysis. Hemodial Int. 10:326–337. 2006. View Article : Google Scholar : PubMed/NCBI
10.	Haris A, Sherrard DJ and Hercz G: Reversal of adynamic bone disease by lowering of dialysate calcium. Kidney Int. 70:931–937. 2006. View Article : Google Scholar : PubMed/NCBI
11.	Afifi A, El-Sayed H, El-Setouhi M, Ahmed H and Khalifa N: Hyperphosphatemia among end-stage renal disease patients in developing countries: a forgotten issue? Hemodial Int. 9:409–415. 2005. View Article : Google Scholar : PubMed/NCBI
12.	Drüeke TB and Touam M: Calcium balance in haemodialysis - do not lower the dialysate calcium concentration too much (con part). Nephrol Dial Transplant. 24:2990–2993. 2009.PubMed/NCBI
13.	Valle C, Rodriguez M, Santamaría R, et al: Cinacalcet reduces the set point of the PTH-calcium curve. J Am Soc Nephrol. 19:2430–2436. 2008. View Article : Google Scholar : PubMed/NCBI
14.	Brown AJ, Koch MJ and Coyne DW: Oral feeding acutely down-regulates serum PTH in hemodialysis patients. Nephron Clin Pract. 103:c106–c113. 2006. View Article : Google Scholar : PubMed/NCBI
15.	Toussaint N, Boddington J, Simmonds R, Waldron C, Somerville C and Agar J: Calcium phosphate metabolism and bone mineral density with nocturnal hemodialysis. Hemodial Int. 10:280–286. 2006. View Article : Google Scholar : PubMed/NCBI
16.	Hwang JC, Chen CA, Wang CT and Chen HC: Long-term effect of different dialysate calcium concentrations on parathyroid hormone levels in hemodialysis patients. Ren Fail. 30:943–951. 2008. View Article : Google Scholar : PubMed/NCBI
17.	Aladrén Regidor MJ: Cinacalcet reduces vascular and soft tissue calcification in secondary hyperparathyroidism (SHPT) in hemodialysis patients. Clin Nephrol. 71:207–213. 2009.PubMed/NCBI
18.	Yokoyama K, Kagami S, Ohkido I, et al: The negative Ca²⁺ balance is involved in the stimulation of PTH secretion. Nephron. 92:86–90. 2002.
19.	Ferreira A, Saraiva M, Behets GE, et al: Valuation of bone remodeling in hemodialysis patients: serum biochemistry, circulating cytokines and bone histomorphometry. J Nephrol. 22:783–793. 2009.PubMed/NCBI
20.	Lund RJ, Andress DL, Amdahl M, et al: Differential effects of paricalcitol and calcitriol on intestinal calcium absorption in hemodialysis patients. Am J Nephrol. 31:165–170. 2010. View Article : Google Scholar : PubMed/NCBI
21.	Yokoyama K, Kagami S, Ohkido I, et al: The negative Ca²⁺ balance is involved in the stimulation of PTH secretion. Nephron. 92:86–90. 2002.
22.	Scholze A, Maier A, Stocks F, et al: Sustained increase of extracellular calcium concentration causes arterial vasoconstriction in humans. J Hypertens. 23:2049–2054. 2005. View Article : Google Scholar : PubMed/NCBI
23.	Wang C, Lou TQ, Chen ZJ, et al: Clinical control study of dialysates with different concentrations of calcium on blood pressure in patients under hemodialysis for prolonged period. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 19:236–238. 2007.(In Chinese).